FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2096006098> ?p ?o ?g. }

• W2096006098 endingPage "1302" @default.
• W2096006098 startingPage "1291" @default.
• W2096006098 abstract "Combination antifungal therapy (amphotericin B deoxycholate and flucytosine) is the recommended treatment for cryptococcal meningitis but has not been shown to reduce mortality, as compared with amphotericin B alone. We performed a randomized, controlled trial to determine whether combining flucytosine or high-dose fluconazole with high-dose amphotericin B improved survival at 14 and 70 days.We conducted a randomized, three-group, open-label trial of induction therapy for cryptococcal meningitis in patients with human immunodeficiency virus infection. All patients received amphotericin B at a dose of 1 mg per kilogram of body weight per day; patients in group 1 were treated for 4 weeks, and those in groups 2 and 3 for 2 weeks. Patients in group 2 concurrently received flucytosine at a dose of 100 mg per kilogram per day for 2 weeks, and those in group 3 concurrently received fluconazole at a dose of 400 mg twice daily for 2 weeks.A total of 299 patients were enrolled. Fewer deaths occurred by days 14 and 70 among patients receiving amphotericin B and flucytosine than among those receiving amphotericin B alone (15 vs. 25 deaths by day 14; hazard ratio, 0.57; 95% confidence interval [CI], 0.30 to 1.08; unadjusted P=0.08; and 30 vs. 44 deaths by day 70; hazard ratio, 0.61; 95% CI, 0.39 to 0.97; unadjusted P=0.04). Combination therapy with fluconazole had no significant effect on survival, as compared with monotherapy (hazard ratio for death by 14 days, 0.78; 95% CI, 0.44 to 1.41; P=0.42; hazard ratio for death by 70 days, 0.71; 95% CI, 0.45 to 1.11; P=0.13). Amphotericin B plus flucytosine was associated with significantly increased rates of yeast clearance from cerebrospinal fluid (-0.42 log10 colony-forming units [CFU] per milliliter per day vs. -0.31 and -0.32 log10 CFU per milliliter per day in groups 1 and 3, respectively; P<0.001 for both comparisons). Rates of adverse events were similar in all groups, although neutropenia was more frequent in patients receiving a combination therapy.Amphotericin B plus flucytosine, as compared with amphotericin B alone, is associated with improved survival among patients with cryptococcal meningitis. A survival benefit of amphotericin B plus fluconazole was not found. (Funded by the Wellcome Trust and the British Infection Society; Controlled-Trials.com number, ISRCTN95123928.)." @default.
• W2096006098 created "2016-06-24" @default.
• W2096006098 creator A5005427167 @default.
• W2096006098 creator A5015147471 @default.
• W2096006098 creator A5016879594 @default.
• W2096006098 creator A5023644790 @default.
• W2096006098 creator A5026484637 @default.
• W2096006098 creator A5028534327 @default.
• W2096006098 creator A5031705923 @default.
• W2096006098 creator A5045016399 @default.
• W2096006098 creator A5046454715 @default.
• W2096006098 creator A5047345915 @default.
• W2096006098 creator A5050689947 @default.
• W2096006098 creator A5051160276 @default.
• W2096006098 creator A5054814065 @default.
• W2096006098 creator A5069436379 @default.
• W2096006098 creator A5073599371 @default.
• W2096006098 creator A5074176680 @default.
• W2096006098 creator A5076197621 @default.
• W2096006098 creator A5078360219 @default.
• W2096006098 creator A5078423875 @default.
• W2096006098 creator A5079806846 @default.
• W2096006098 creator A5081940608 @default.
• W2096006098 creator A5083495214 @default.
• W2096006098 creator A5087777785 @default.
• W2096006098 date "2013-04-04" @default.
• W2096006098 modified "2023-10-10" @default.
• W2096006098 title "Combination Antifungal Therapy for Cryptococcal Meningitis" @default.
• W2096006098 cites W1925125631 @default.
• W2096006098 cites W2004815652 @default.
• W2096006098 cites W2034698532 @default.
• W2096006098 cites W2064009861 @default.
• W2096006098 cites W2069625203 @default.
• W2096006098 cites W2079513681 @default.
• W2096006098 cites W2100980414 @default.
• W2096006098 cites W2132441677 @default.
• W2096006098 cites W2139861350 @default.
• W2096006098 cites W2143732246 @default.
• W2096006098 cites W2143769286 @default.
• W2096006098 cites W2143928313 @default.
• W2096006098 cites W2144543496 @default.
• W2096006098 cites W2148002357 @default.
• W2096006098 cites W2149684675 @default.
• W2096006098 cites W2150702714 @default.
• W2096006098 cites W2163128219 @default.
• W2096006098 cites W2165882694 @default.
• W2096006098 cites W2315224357 @default.
• W2096006098 cites W2317790888 @default.
• W2096006098 cites W2331249764 @default.
• W2096006098 cites W4385997046 @default.
• W2096006098 doi "https://doi.org/10.1056/nejmoa1110404" @default.
• W2096006098 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3978204" @default.
• W2096006098 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23802521" @default.
• W2096006098 hasPublicationYear "2013" @default.
• W2096006098 type Work @default.
• W2096006098 sameAs 2096006098 @default.
• W2096006098 citedByCount "417" @default.
• W2096006098 countsByYear W20960060982013 @default.
• W2096006098 countsByYear W20960060982014 @default.
• W2096006098 countsByYear W20960060982015 @default.
• W2096006098 countsByYear W20960060982016 @default.
• W2096006098 countsByYear W20960060982017 @default.
• W2096006098 countsByYear W20960060982018 @default.
• W2096006098 countsByYear W20960060982019 @default.
• W2096006098 countsByYear W20960060982020 @default.
• W2096006098 countsByYear W20960060982021 @default.
• W2096006098 countsByYear W20960060982022 @default.
• W2096006098 countsByYear W20960060982023 @default.
• W2096006098 crossrefType "journal-article" @default.
• W2096006098 hasAuthorship W2096006098A5005427167 @default.
• W2096006098 hasAuthorship W2096006098A5015147471 @default.
• W2096006098 hasAuthorship W2096006098A5016879594 @default.
• W2096006098 hasAuthorship W2096006098A5023644790 @default.
• W2096006098 hasAuthorship W2096006098A5026484637 @default.
• W2096006098 hasAuthorship W2096006098A5028534327 @default.
• W2096006098 hasAuthorship W2096006098A5031705923 @default.
• W2096006098 hasAuthorship W2096006098A5045016399 @default.
• W2096006098 hasAuthorship W2096006098A5046454715 @default.
• W2096006098 hasAuthorship W2096006098A5047345915 @default.
• W2096006098 hasAuthorship W2096006098A5050689947 @default.
• W2096006098 hasAuthorship W2096006098A5051160276 @default.
• W2096006098 hasAuthorship W2096006098A5054814065 @default.
• W2096006098 hasAuthorship W2096006098A5069436379 @default.
• W2096006098 hasAuthorship W2096006098A5073599371 @default.
• W2096006098 hasAuthorship W2096006098A5074176680 @default.
• W2096006098 hasAuthorship W2096006098A5076197621 @default.
• W2096006098 hasAuthorship W2096006098A5078360219 @default.
• W2096006098 hasAuthorship W2096006098A5078423875 @default.
• W2096006098 hasAuthorship W2096006098A5079806846 @default.
• W2096006098 hasAuthorship W2096006098A5081940608 @default.
• W2096006098 hasAuthorship W2096006098A5083495214 @default.
• W2096006098 hasAuthorship W2096006098A5087777785 @default.
• W2096006098 hasBestOaLocation W20960060981 @default.
• W2096006098 hasConcept C126322002 @default.
• W2096006098 hasConcept C141071460 @default.
• W2096006098 hasConcept C16005928 @default.
• W2096006098 hasConcept C168563851 @default.
• W2096006098 hasConcept C203014093 @default.

• next